Insmed (INSM) Reports Q4 Loss of $0.85/Share
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $98.61 +2.93%
Revenue Growth %: +264.2%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +264.2%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q4 EPS of ($0.85), versus ($1.10) reported last year.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
